Vivo Bio Tech: Board Meeting Outcome for Un-Audited Standalone & Consolidated Financial Results Of The Company For The Third Quarter And Nine Months Ended December 31 2025

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

For grievances: [email protected]